Medibank Private Limited (ASX:MPL – Get Free Report) insider Peter Everingham acquired 25,000 shares of the company’s stock in a transaction dated Friday, February 27th. The shares were bought at an average price of A$4.41 per share, for a total transaction of A$110,250.00.
Medibank Private Stock Performance
The company has a market cap of $11.94 billion, a price-to-earnings ratio of 25.67 and a beta of 0.03.
Medibank Private Announces Dividend
The company also recently disclosed a Interim dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Tuesday, March 17th will be paid a dividend of $0.083 per share. The ex-dividend date is Wednesday, February 25th. This represents a dividend yield of 186.0%. Medibank Private’s payout ratio is currently 102.78%.
About Medibank Private
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students.
Featured Articles
- Five stocks we like better than Medibank Private
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- [How To] Invest Pre-IPO In SpaceX With $100!
Receive News & Ratings for Medibank Private Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medibank Private and related companies with MarketBeat.com's FREE daily email newsletter.
